Literature DB >> 17341174

Pharmacological treatment of bipolar disorder among children and adolescents.

Joseph C Blader1, Vivian Kafantaris.   

Abstract

There is growing recognition that bipolar disorder frequently first presents in adolescence. Preadolescents with volatile behavior and severe mood swings also comprise a large group of patients whose difficulties may lie within the bipolar spectrum. However, the preponderance of scientific effort and clinical trials for this condition has focused on adults. This review summarizes the complexity of bipolar disorder and diagnosis of the disease among young people. It proceeds to review the principles of pharmacotherapy, assess current treatment options and to highlight areas where evidence-based guidance is lacking. Recent developments have enlarged the range of potential treatments for bipolar disorder. Nonetheless, differences in the phenomenology, course and sequelae of bipolar disorder among young people compel greater attention to the benefits and liabilities of therapy for those affected by this illness' early onset. By summarizing current research and opinion on diagnostic issues and treatment approaches, this review aims to provide an update on a clinically important yet controversial topic.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17341174      PMCID: PMC2946413          DOI: 10.1586/14737175.7.3.259

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  101 in total

1.  Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.

Authors:  Trisha Suppes; Eileen Brown; Leslie M Schuh; Robert W Baker; Mauricio Tohen
Journal:  J Affect Disord       Date:  2005-10-25       Impact factor: 4.839

2.  Changes in child and adolescent inpatient psychiatric admission diagnoses between 1995 and 2000.

Authors:  Ilan Harpaz-Rotem; Douglas L Leslie; Andres Martin; Robert A Rosenheck
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-08-18       Impact factor: 4.328

3.  Familiality and heritability of subtypes of attention deficit hyperactivity disorder in a population sample of adolescent female twins.

Authors:  R D Todd; E R Rasmussen; R J Neuman; W Reich; J J Hudziak; K K Bucholz; P A Madden; A Heath
Journal:  Am J Psychiatry       Date:  2001-11       Impact factor: 18.112

4.  Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.

Authors:  Gabriele S Leverich; Lori L Altshuler; Mark A Frye; Trisha Suppes; Susan L McElroy; Paul E Keck; Ralph W Kupka; Kirk D Denicoff; Willem A Nolen; Heinz Grunze; Maria I Martinez; Robert M Post
Journal:  Am J Psychiatry       Date:  2006-02       Impact factor: 18.112

5.  Stage 2 of the Wellcome Trust UK-Irish bipolar affective disorder sibling-pair genome screen: evidence for linkage on chromosomes 6q16-q21, 4q12-q21, 9p21, 10p14-p12 and 18q22.

Authors:  D Lambert; F Middle; M L Hamshere; R Segurado; R Raybould; A Corvin; E Green; E O'Mahony; I Nikolov; T Mulcahy; S Haque; S Bort; P Bennett; N Norton; M J Owen; G Kirov; C Lendon; L Jones; I Jones; P Holmans; M Gill; N Craddock
Journal:  Mol Psychiatry       Date:  2005-09       Impact factor: 15.992

6.  Adjunctive antipsychotic treatment of adolescents with bipolar psychosis.

Authors:  V Kafantaris; D J Coletti; R Dicker; G Padula; J M Kane
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-12       Impact factor: 8.829

Review 7.  Acute treatment of mania: an update on new medications.

Authors:  Prashant Gajwani; David E Kemp; David J Muzina; Guohua Xia; Keming Gao; Joseph R Calabrese
Journal:  Curr Psychiatry Rep       Date:  2006-12       Impact factor: 5.285

8.  Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.

Authors:  Russell E Scheffer; Robert A Kowatch; Thomas Carmody; A John Rush
Journal:  Am J Psychiatry       Date:  2005-01       Impact factor: 18.112

9.  The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders.

Authors:  E J Costello; A Angold; B J Burns; D K Stangl; D L Tweed; A Erkanli; C M Worthman
Journal:  Arch Gen Psychiatry       Date:  1996-12

10.  Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania.

Authors:  Mani N Pavuluri; David B Henry; Julie A Carbray; Gwendolyn Sampson; Michael W Naylor; Philip G Janicak
Journal:  J Affect Disord       Date:  2004-10       Impact factor: 4.839

View more
  2 in total

1.  A prospective investigation of suicide ideation, attempts, and use of mental health service among adolescents in substance abuse treatment.

Authors:  Rajeev Ramchand; Beth Ann Griffin; Katherine M Harris; Daniel F McCaffrey; Andrew R Morral
Journal:  Psychol Addict Behav       Date:  2008-12

2.  Database analysis of children and adolescents with bipolar disorder consuming a micronutrient formula.

Authors:  Julia J Rucklidge; Dermot Gately; Bonnie J Kaplan
Journal:  BMC Psychiatry       Date:  2010-09-28       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.